摘要 |
The present invention refers to a drug combination, drug association, a drug, and a drug presenting a facilitated presentation comprising, individually, and at the same time, jointly: one or more drug units containing on or more proton pump inhibitor agents; one or more drug units containing one or more prokinetic agents; and optionally, other additives or drugs which are well-known to those skilled in the art, within a medium or excipient, also pharmaceutically acceptable, preferably used for the treatment of functional dyspepsia and gastroesophageal reflux disease. |